Peripheral Vascular Devices Market

The report "Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Hemodynamic flow alteration devices), Region - Forecast to 2029", is valued at an estimated 11.43 billion in 2024 and is projected to reach USD 14.73 billion by 2029, at a CAGR of 5.2% during the forecast period.

Browse 365 market data Tables and 52 Figures spread through 323 Pages and in-depth TOC on "Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Hemodynamic flow alteration devices), Region - Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/interventional-cardiology-peripheral-vascular-devices-market-790.html

Peripheral vascular devices market growth drivers include several key factors. First, PVD is rising due to lifestyle-related factors such as obesity, diabetes, smoking, and an aging population. And increasingly diagnosed conditions like PAD lead the way to increasing demand of treatments such as angioplasty, stenting, and other revascularization procedures. Technological advancement in minimally invasive devices such as drug-eluting stents (DES), bioresorbable stents, and advanced catheters also benefit the market, making procedures safer and effective hence adopted more by physicians. The market further increases in awareness and screening for PVD, which helps in early detection and treatment of vascular diseases.

In addition, favorably undertaken reimbursement policies, particularly in developed regions, including the U.S. and Europe, increase the sale of these advanced devices among hospitals and other healthcare service-providing facilities. The investments being made in the infrastructures of health care and the increasing interventional procedures across the world, especially in emerging markets, are also multiplying the growth of the market. Finally, the increase in healthcare expenditures along with strategies for reducing the number of amputations, coupled with early interventions, have furthered the growth of demand

“By Type, Angioplasty stents hold the largest share in 2023.”

The peripheral vascular devices market is divided by type into the following segments – Angioplasty Stents, Angioplasty Balloons , Catheters, Endovascular aneurysm repair graft stent graft, Inferior cava filters, Plaque moficcation devices, Hemodynamic flow alteration devices and other peripheral vascular devices. Angioplasty stents hold a larger share of the market for peripheral vascular devices than angioplasty balloons, catheters, and EVAR devices due to various reasons. Stents are more permanent as they hold the blood vessels open after an angioplasty procedure, thus reducing a very common phenomenon- restenosis- after balloon angioplasty. Drug-eluting stents (DES), in that they release medication to prevent tissue growth that may occlude the artery again, have further enhanced the clinical outcomes of patients as compared to traditional angioplasty techniques. In addition, stents are favored for highly complex cases with severe, mostly calcified areas where the arteries are extensively narrowed, bringing in an additional group of patients to whom the procedure can be offered.

Angioplasty balloons, though necessary in the initial stages of dilating vessels, cause more problems of elastic recoil and are thus a more viable choice for maintaining long-term patency with stents instead. In addition, advancement in technology and the success of clinical trials has seen the increased use of newer stent designs over balloons as well as other devices such as catheters and EVAR systems. The fact that these stents enjoy higher success rates and lower complication rates than bare-metal stents makes them the first choice among alternative choices physicians and patients may have, thus increasing their market share.

“North America dominates the global Peripheral Vascular devices market in 2023.”

The Peripheral vascular devices Market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. In 2023 North America accounted for the largest share during the forecast period .The key factors driving the large share of North America in the peripheral vascular devices market can be attributed to improved healthcare infrastructure, accessibility to advanced technologies, and highly professional practitioners. There are also several patients with PVD conditions, considering the risk factors of the diseases, particularly diabetes and obesity, and aging. Increasing numbers of patients in the North America, especially in the U.S, undergo surgical procedures including angioplasty and stenting. Medicare and private insurance offer positive reimbursement policies that enhance the use of these devices. The major medical equipment manufacturers of firms like Medtronic, Abbott, and Boston Scientific are headquartered in this region, so there is emerging innovation as well as extensive availability of superior vascular devices?

Key Players:

The prominent companies are Boston Scientific (US), Medtronic Plc (US), Abbott (US), Becton, Dickinson and Company(US), Terumo Corporation(Japan), B. Braun Melsungen AG(Germany), Merit Medical Systems(US) among others.

Don’t miss out on business opportunities in Peripheral Vascular Devices Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]